Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.670
-0.040 (-2.34%)
At close: Feb 11, 2026, 4:00 PM EST
1.690
+0.020 (1.20%)
After-hours: Feb 11, 2026, 5:26 PM EST
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $15.76 million as of February 11, 2026. Its market cap has decreased by -36.58% in one year.
Market Cap
15.76M
Enterprise Value
24.84M
1-Year Change
-36.58%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $15.76M, a decrease of -84.77%. That is a compound annual growth rate of -30.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 16.14M | -11.55% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regentis Biomaterials | 25.90M |
| IRIDEX | 25.44M |
| Nortech Systems | 23.85M |
| Adagio Medical Holdings | 22.24M |
| Trinity Biotech | 16.00M |
| Vicarious Surgical | 14.59M |
| Allurion Technologies | 13.88M |
| Beyond Air | 11.95M |